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Abstract
Background: The high costs of pyridine nucleotide cofactors have limited the applications of NAD(P)-dependent
oxidoreductases on an industrial scale. Although NAD(P)H regeneration systems have been widely studied, NAD(P)
+
regeneration, which is required in reactions where the oxidized form of the cofactor is used, has been less well explored,
particularly in whole-cell biocatalytic processes.
Methodology/Principal Findings: Simultaneous overexpression of an NAD
+ dependent enzyme and an NAD
+ regenerating
enzyme (H2O producing NADH oxidase from Lactobacillus brevis) in a whole-cell biocatalyst was studied for application in
the NAD
+-dependent oxidation system. The whole-cell biocatalyst with (2R,3R)-2,3-butanediol dehydrogenase as the
catalyzing enzyme was used to produce (3R)-acetoin, (3S)-acetoin and (2S,3S)-2,3-butanediol.
Conclusions/Significance: A recombinant strain, in which an NAD
+ regeneration enzyme was coexpressed, displayed
significantly higher biocatalytic efficiency in terms of the production of chiral acetoin and (2S,3S)-2,3-butanediol. The
application of this coexpression system to the production of other chiral chemicals could be extended by using different
NAD(P)-dependent dehydrogenases that require NAD(P)
+ for catalysis.
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Introduction
Many approaches have been developed to produce chiral
chemicals for the manufacture of a wide range of intermediates in
the pharmaceutical, agrochemical, fine chemical and food indus-
tries [1]. In recent years, biocatalysis has emerged as a powerful
strategy for the production of enantiomerically pure building blocks
that cannot be obtained through chemical and fermentation
processes [2]. NAD(P)-dependent oxidation systems have been
used for the kinetic resolution of chiral alcohols and amines from a
mixture of stereoisomers and for the production of ketones that are
difficult to synthesize chemically [3–4]. However, due to the high
costs of pyridine cofactors, an efficient cofactor regeneration system
is a prerequisite for the commercial viability of a process [5–6].
Whole cells have some NAD
+ and NADP
+ reserves that provide
a continuous source of cofactors [7]. Therefore, whole cells are
used in many applications of dehydrogenases. Simultaneous
overexpression of target enzymes and NAD(P)H regeneration
enzymes in whole-cell biocatalysts has been carried out in many
asymmetric reduction systems [8–9]. In this study, NAD
+
regeneration by whole-cell biocatalysis was used to extend the
applications of NAD(P)
+-dependent oxidoreductases.
Chiral acetoin (AC) is widely used to synthesize novel optically
active a-hydroxyketone derivatives and liquid crystal composites
[10]. Chemical syntheses or fermentations generally lead to the
production of a mixture of both isomers [11]. Therefore, it is
essential to find an effective biocatalytic process to produce
enantiomerically pure AC. In the presence of NAD
+, NAD-
dependent (2R,3R)-2,3-butanediol dehydrogenase (BDH) can
theoretically catalyze the stereospecific oxidation of (2R,3R)-2,3-
butanediol (BD) and meso-2,3-BD to (3R)-AC and (3S)-AC, as
shown in Scheme S1, respectively [12–14].
Similar to other dehydrogenases, BDHs require NAD
+ and
NADH as cofactors [12–14]. During the catalytic process, NAD
+
is reduced to NADH, and 2,3-BD is oxidized to AC. Thus, during
the course of one cycle, NAD
+ is depleted while NADH and AC
are accumulated. A cofactor regeneration process is necessary to
obtain high AC productivity. In contrast to the more common
NADH oxidase (NOX) that converts O2 to H2O2, the unique
NOX from Lactobacillus brevis regenerates NAD
+ from NADH by
reducing O2 to H2O [15–18]. Since proteins are deactivated upon
exposure to H2O2, the novel characteristics of the NOX from L.
brevis make it a promising alternative for NAD
+ regeneration. In
this study, we developed a coexpression system in which acetoin
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8860reductase/2,3-BDH encoded by the Bacillus subtilis ydjL (bdhA) gene
was the producing enzyme and NOX was the cofactor-
regenerating enzyme. Our intention was to develop a novel
biocatalytic process for the efficient production of (3R)-AC and
(3S)-AC with high enantiomeric excess (ee).
Results and Discussion
Construction of the Whole-Cell Biocatalyst
First, Escherichia coli BL21(DE3) (pETDuet-ydjL) carrying ydjL,
which encodes (2R,3R)-2,3-BDH from B. subtilis 168 was
constructed. The crude extract of induced E. coli BL21(DE3)
(pETDuet-ydjL) cells showed a high (2R,3R)-2,3-BDH activity of
16.0 U mg
21 (in the direction of (2R,3R)-2,3-BD production).
Next, E. coli BL21(DE3) (pETDuet-nox) harboring nox, which
encodes NOX from L. brevis, was constructed. The crude extract of
induced E. coli BL21(DE3) (pETDuet-nox) cells showed a high
NOX activity of 7.2 U mg
21 (SDS-PAGE analyses of the
recombinant proteins are shown in Fig. 1). The biocatalytic
activities of the crude extracts prepared from E. coli BL21(DE3)
(pETDuet-nox) and E. coli BL21(DE3) (pETDuet-ydjL) cells were
assayed using meso-2,3-BD and (2R,3R)-2,3-BD as the substrates.
However, no notable production of AC was detected.
In comparison with free enzymes, whole-cell biocatalysts are
much more convenient to use and less expensive to prepare [19].
Enzymes in whole cells are more stable than isolated enzymes
because these are protected from the external environment. The
biocatalytic activities of the whole-cell biocatalyst prepared from E.
coli BL21(DE3) (pETDuet-ydjL) were determined using meso-2,3-
BD, (2R,3R)-2,3-BD, and (2S,3S)-2,3-BD as the substrates. As
shown in Table 1, the whole-cell biocatalyst of E. coli BL21(DE3)
(pETDuet-ydjL) had almost the same biocatalytic activities on meso-
2,3-BD and (2R,3R)-2,3-BD but had no activity on (2S,3S)-2,3-BD.
To obtain high AC productivity, we decided to couple a
cofactor regeneration system, in which biocatalysis was performed
using whole cells of both E. coli BL21(DE3) (pETDuet-ydjL) and E.
coli BL21(DE3) (pETDuet-nox) as catalysts. However, no enhance-
ment of the biocatalytic activity of E. coli BL21(DE3) (pETDuet-
ydjL) system was detected with supplemented whole cells of E. coli
BL21(DE3) (pETDuet-nox). This may be due to the fact that
(2R,3R)-2,3-BDH and NOX are physically separated and
expressed in different cells, and the cellular membrane of the
cells might retard the exchange of pyridine cofactors between E.
coli BL21(DE3) (pETDuet-nox) and E. coli BL21(DE3) (pETDuet-
ydjL). To validate this observation, E. coli BL21(DE3) (pETDuet-
ydjLnox) cells were constructed in which NOX, the NAD
+
regeneration enzyme, was coexpressed with (2R,3R)-2,3-BDH,
the catalyzing enzyme, as shown in Fig. 1.
Although the two genes were coexpressed on one expression
vector, they were placed under two separate T7 lac promoters so
that the expression of one gene would not affect that of the other.
NOX could oxidize the NADH produced by (2R,3R)-2,3-BDH
and provide the oxidized form of the pyridine nucleotide cofactor
for the biocatalytic process, without any hindrance from the
transmembrane process. As shown in Table 1, the whole-cell
biocatalytic activity of E. coli BL21(DE3) (pETDuet-ydjLnox)o n
meso-2,3-BD (15.8 U mL
21) was about twice that of E. coli
BL21(DE3) (pETDuet-ydjL) (8.1 U mL
21). The results indicated
that recombinant E. coli BL21(DE3) (pETDuet-ydjLnox) could
increase biocatalytic efficiency of BDH by co-expressing an NAD
+
regeneration enzyme. Production of (3S)-AC, (3R)-AC, and
(2S,3S)-2,3-BD was possible using E. coli BL21(DE3) (pETDuet-
ydjLnox) as the biocatalyst and 2,3-BD as the substrate, as shown in
Fig. 2.
Effects of pH and Substrate Concentration on Chiral AC
Biosynthesis
To achieve high product concentrations, the effect of pH on the
yield of AC from 2,3-BD was investigated. As shown in Fig. 3A,
reactions with 43.0 g L
21 of meso-2,3-BD as the substrate and
5.0 g dry cell weight (DCW) L
21 of E. coli BL21(DE3) (pETDuet-
ydjLnox) as the biocatalyst were carried out under different
conditions. After 6 h of reaction with E. coli BL21(DE3)
(pETDuet-ydjLnox), the reaction rates were measured by monitor-
Figure 1. SDS-PAGE analysis of recombinant E. coli. Lane M,
marker proteins; lane 1, E. coli BL21(DE3); lane 2, E. coli BL21(DE3)
(pETDuet); lane 3, E. coli BL21(DE3) (pETDuet-ydjL); lane 4, E. coli
BL21(DE3) (pETDuet-nox); and lane 5, E. coli BL21(DE3) (pETDuet-
ydjLnox).
doi:10.1371/journal.pone.0008860.g001
Table 1. The whole-cell biocatalytic activity of recombinant E. coli with 2,3-BD.
E. coli strain Whole-cell biocatalytic ability (U mL
21)
meso-2,3-BD (2R,3R)-2,3-BD (2S,3S)-2,3-BD
BL21 (DE3) (pETDuet) 0.3 (60.00) 0.3 (60.07) ND
BL21 (DE3) (pETDuet-ydjL) 8.1 (60.91) 8.9 (60.74) ND
BL21 (DE3) (pETDuet-ydjL) and BL21 (DE3) (pETDuet-nox) 7.71 (60.00) 8.02 (60.56) ND
BL21 (DE3) (pETDuet-ydjLnox) 15.8 (61.24) 14.4 (61.24) ND
ND: not detected.
doi:10.1371/journal.pone.0008860.t001
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was the highest at pH 8.0. It was reported that the optimum pH
value for the conversion of 2,3-BD to AC by (2R,3R)-2,3-BDH was
9.0 and 5.5,7.0 for NOX [13,18]. When the two enzymes were
coexpressed and functioned together, the optimum pH value was
8.0.
Substrate concentration is another important parameter in the
catalytic process, and it requires careful investigation because high
substrate concentrations may lead to substrate inhibition. The
effect of the substrate concentration on the conversion rate was
tested (Fig. 3B). The results showed that in the range 8,61 g L
21,
the conversion rate of meso-2,3-BD decreased sharply from 100%
to 47.5% as the concentration increased. Simultaneously, the
concentration of (3S)-AC increased linearly with the increase in the
substrate concentration from 8 g L
21 to 43 g L
21, but when the
substrate concentration increased beyond 43 g L
21, the concen-
tration of (3S)-AC decreased rapidly. It is known that AC can be
easily separated from the reaction solution due to its low boiling
point and that residual 2,3-BD can be reused. Therefore, 43 g L
21
of meso-2,3-BD was selected as a suitable substrate concentration
based on the final yield of (3S)-AC.
Production of Chiral AC by Recombinant E. coli
To evaluate the efficiency of whole-cell in the biosynthesis of
chiral AC, recombinants E. coli BL21(DE3) (pETDuet-ydjLnox) and
E. coli BL21(DE3) (pETDuet-ydjL) were used to catalyze the
conversion of meso-2,3-BD to (3S)-AC (E. coli BL21(DE3) was used
as the control). As shown in Fig. 4, under optimal reaction
conditions, the final concentration of (3S)-AC produced by
recombinant E. coli BL21(DE3) (pETDuet-ydjLnox) was
36.7 g L
21 from 43 g L
21 of meso-2,3-BD in 12 h. In comparison,
only 17.8 g L
21 of (3S)-AC was produced by recombinant E. coli
BL21(DE3) (pETDuet-ydjL) under identical conditions. Low
conversion rate was observed by the wild-type E. coli BL21(DE3)
strain, and the final concentration of (3S)-AC was only 0.6 g L
21.
When (2R,3R)-2,3-BD was used as the substrate, (3R)-AC was
produced. The highest concentration of (3R)-AC (41.8 g L
21) was
obtained when the concentration of (2R,3R)-2,3-BD was 43 g L
21.
Since (3S)-AC and (3R)-AC standards could be separated by GC,
the ee of the products was calculated by the amount of each
isomer. The two isomers of AC were produced in 96.0% ee. The
results from GC analyses of substrates and products of the catalytic
reaction are shown in Fig. 5A, B.
The production of chiral AC by biocatalysis has been reported
earlier [20–21]. Yamada-Onodera et al. reported that about
9.68 g L
21 of both (3R)-AC from (2R,3R)-2,3-BD and (3S)-AC
from meso-2,3-BD were obtained after 24 h of incubation with
recombinant E. coli expressing only glycerol dehydrogenase (GDH)
[20]. In this study, a recombinant strain that coexpressed (2R,3R)-
2,3-BDH and NOX was constructed, and the yield of both (3S)-
AC and (3R)-AC was found to be much higher than that in
previous reports. The results also showed that the recombinant
strain that coexpressed (2R,3R)-2,3-BDH and NOX was signifi-
cantly more efficient than the recombinant strain that only
expressed (2R,3R)-2,3-BDH in terms of AC production. As shown
in Fig. 4, the yield of (3S)-AC from the two-enzyme system was
42.8% higher than that from the one-enzyme system (similar result
was found for (3R)-AC production, data not shown).
(2S,3S)-2,3-BD Production by Kinetic Resolution
2,3-BD, the hydrogenation product of AC, is not only used as a
fuel, but also as a valuable chemical feedstock [22–23]. (2S,3S)-2,3-
BD can also be used as an antifreeze agent due to its low freezing
point (260uC) [22–23]. However, to date, no microorganism
capable of producing enantiopure (2S,3S)-2,3-BD has been
identified. In this study, (2S,3S)-2,3-BD was produced by kinetic
resolution from a mixture of 2,3-BD using the whole-cell
biocatalyst of E. coli BL21(DE3) (pETDuet-ydjLnox). When a
mixture of 20.0 g L
21 2,3-BD was incubated with E. coli
Figure 2. A recombinant E. coli whole-cell biocatalyst with BDH
and the enzymatic NAD regeneration system for the produc-
tion of chiral AC and (2S,3S)-2,3-BD.
doi:10.1371/journal.pone.0008860.g002
Figure 3. Effects of biocatalysis conditions on the reaction rate. A. pH; B. substrate concentration. E. coli BL21(DE3) (pETDuet-ydjLnox) was
incubated with meso-2,3-BD in the reaction.
doi:10.1371/journal.pone.0008860.g003
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21 of
(2S,3S)-2,3-BD and 17.2 g L
21 of AC were produced in 10 h, and
the ee of the (2S,3S)-2,3-BD finally obtained was higher than
99.0%. The results from GC analyses of substrates and products of
the catalytic reaction are shown in Fig. 5C.
Although the yield of (2S,3S)-2,3-BD was not very high due to
the low content of (2S,3S)-2,3-BD in the mixture of 2,3-BD (only
12.4%), the biocatalytic efficiency of the (2R,3R)-2,3-BDH and
NOX coexpressing recombinant strain was much higher than that
of recombinant E. coli expressing GDH only (1.4 g L
21) [20]. This
shows that the incorporation of a cofactor regeneration system in
the E. coli whole-cell biocatalyst is a powerful strategy for
enhancing the catalytic efficiency of oxidoreductases.
Many dehydrogenases that are useful in industrial production
are cofactor-dependent. By using a suitable enantioselective
dehydrogenase, important enantiomerically pure compounds can
be prepared by kinetic resolution. For example, NAD
+ dependent
(S)-ADH can be used for the production of (R)-phenylethanol from
a racemate with 100% ee and 100% yield. Regeneration of the
cofactor is important in large-scale applications of coenzyme-
dependent reactions [24]. NAD(P)H regeneration has been widely
studied, whereas NAD(P)
+ regeneration, which is required for
reactions involving the oxidized forms of the pyridine nucleotide
cofactors, is less well developed [15]. An NAD-dependent alcohol
dehydrogenase from L. brevis coupled with the NOX from
Lactobacillus sanfranciscensis was successfully used to produce
enantiomerically pure alcohol from a racemic mixture [15]. The
two enzymes were first purified, and then coupled in a reaction in
which NOX was used to regenerate the oxidized cofactor.
Although this method did not generate any byproducts, the
complex purification processes and the oxygen sensitivity of NOX
precluded its applications on a preparative scale [3].
In comparison with isolated enzymes, utilization of whole-cell
biocatalysts circumvents laborious protein purification steps, which
simplifies the reactions in many cases. NAD(P)
+ regeneration in
whole-cell biocatalysts would help in extending the applications of
NAD(P)-dependent oxidoreductases. In this study, we constructed
a novel whole-cell biocatalyst from recombinant E. coli in which
(2R,3R)-2,3-BDH and NOX were coexpressed to catalyze the
production of (3R)-AC, (3S)-AC, and (2S,3S)-2,3-BD with high ee.
The present study clearly demonstrates the importance of
providing sufficient amounts of the oxidized form of the pyridine
nucleotide cofactors to NAD-dependent dehydrogenases. The
value of the NAD
+ regeneration technique presented in this paper
could extend beyond chiral AC and (2S,3S)-2,3-BD production to
other chiral chemicals. Coupling NOX from L. brevis in the
biocatalytic system provided a suitable method for NAD
+
regeneration, and this should open up the possibilities for
constructing other whole-cell biocatalysts with different NAD-
dependent dehydrogenases.
Materials and Methods
Chemicals
Meso-2,3-BD (98.0%) and (2R,3R)-2,3-BD (98.0%) were pur-
chased from ACROS. The mixture of 2,3-BD (75.0% meso-2,3-
BD, 12.6% (2R,3R)-2,3-BD, and 12.4% (2S,3S)-2,3-BD) was
obtained from Sinopharm (Beijing, China). Ampicillin and NADH
were from Amresco. Isopropyl-b-D-1-thiogalactopyranoside
(IPTG) and phenylmethanesulfonyl fluoride (PMSF) were from
Merck. All other chemicals were commercially available reagents
of analytical grade. PCR primers were prepared by Sangon
(Shanghai, China). Pfu DNA polymerase was obtained from
Promega (USA). T4 DNA ligase and restriction endonucleases
were obtained from Fermentas (Lithuania).
Constructions of E. coli BL21(DE3) (pETDuet-ydjL), E. coli
BL21(DE3) (pETDuet-nox) and E. coli BL21(DE3) (pETDuet-
ydjLnox)
The bacterial strains and plasmids used in this study are listed in
Table 2. B. subtilis 168 genomic DNA was extracted with the
Wizard Genomic DNA Purification Kit (Promega, Madison, WI,
USA). The ydjL gene was amplified by PCR using forward primer
py1 with an NcoI restriction site insertion and reverse primer py2
with a SalI restriction site insertion. The PCR product was firstly
ligated to the pEasy-Blunt vector, and the resulting plasmid was
designated pEasy-Blunt-ydjL. The pEasy-Blunt-ydjL was then
sequenced (Sangon, Shanghai, China) to verify that no mutations
were introduced by PCR. Next, to construct the recombinant
plasmid pETDuet-ydjL under the control of the T7 promoter,
pEasy-Blunt-ydjL was digested with NcoI and SalI, and the gel-
Figure 4. Time course of the recombinant E. coli whole-cell biocatalyst-mediated (3S)-AC production from meso-2,3-BD by the
recombined E. coli. The concentration of (3S)-AC (%) and meso-2,3-BD (&)i nE. coli BL21(DE3) (pETDuet-ydjLnox) ; concentrations of (3S)-AC (#)
and meso-2,3-BD (N)i nE. coli BL21(DE3) (pETDuet-ydjL); and concentrations of (3S)-AC (n) and meso-2,3-BD (m)i nE. coli BL21(DE3).
doi:10.1371/journal.pone.0008860.g004
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had been digested with the same restriction enzymes. Using the
same process that described above, the nox gene fragment was
obtained from the genome of L. brevis using primers pn1 (with the
BglII restriction site) and pn2 (with the XhoI restriction site). To
construct a coexpression system carrying ydjL and nox, pEasy-
Blunt-nox was digested with BglII and XhoI, and the gel-purified nox
fragment was ligated to pETDuet-ydjL digested with the same
restriction enzymes. E. coli DH5a was used for general cloning,
and E. coli BL21(DE3) was used for protein expression. Luria-
Bertani (LB) medium was used for both E. coli and B. subtilis
culture. DeMan-Rogosa Sharpe (MRS) medium was used for L.
brevis culture.
Biocatalyst Preparation
Recombinant E. coli cells were grown at 37uC on a rotary shaker
(180 rpm) in LB medium containing ampicillin (100 mgm L
21)t o
an OD620nm value of 0.6. Expression of the recombinant gene was
induced by adding 1 mM IPTG at 16uC to avoid the formation of
inactive inclusion bodies. After induction, the cells were harvested
by centrifugation at 6,0006g for 5 min at 4uC and then washed
twice with 1/15 M phosphate buffer (PB) (pH 7.4). The cell pellet
was resuspended in 1/15 M PB (pH 7.4), and maintained at 4uC
for further studies.
(2R,3R)-2,3-BDH and NOX Activity Assays
The harvested cells were resuspended in 20% glycerol,
0.1 mM PMSF, and 1 mM DTT in 1/15 M PB (pH 7.4) and
disrupted for 20 min (5 s + 5 s) using a sonicator. The disrupted
cells were centrifuged for 10 min at 10,0006g at 4uC, and the
supernatant was used as the crude cell extract. The (2R,3R)-2,3-
BDH and NOX activities were assayed by measuring the
decrease in NADH (0.2 mM) at 340 nm using a UV/visible
spectrophotometer (Ultrospec 2100 pro, Amersham Biosciences,
USA) [18,25]. The protein concentration was determined by the
Bradford method using bovine serum albumin as the standard
[26].
Assay of Whole-Cell Biocatalytic Activity
The whole-cell biocatalytic activity was assayed by measuring
the increase of AC in the reaction solution. The reaction solution
consisting of 10.0 g L
21 2,3-BD and the whole-cell biocatalyst (the
final concentration was 1.5 g DCW L
21) in 200 mM PB (pH 8.0)
was incubated at 37uC on a rotary shaker for 20 min. The mixture
was centrifuged at 6,0006g for 5 min to stop the reaction, and the
AC concentration in the supernatant was measured. One unit of
whole-cell biocatalytic activity was defined as the amount of cells
that catalyzed the formation of 1.0 mmol of AC per minute at
37uC.
Biocatalysis Conditions
Reaction with 20 mL of mixture in a 250-mL Erlenmeyer flask
at 37uC and 200 rpm were performed at pH 8.0. The cell
concentration in the reaction was 5.0 g DCW L
21. To produce
chiral AC, the harvested biocatalyst was resuspended in 200 mM
PB (pH 8.0) containing 43 g L
21 meso-2,3-BD or (2R,3R)-2,3-BD.
For the kinetic resolution of (2S,3S)-2,3-BD from the 2,3-BD
mixture, the harvested biocatalyst was resuspended in 200 mM PB
(pH 8.0) containing 20 g L
21 of 2,3-BD.
Product Analysis
Samples (0.15 mL) were taken periodically and centrifuged at
15,0006g. The concentrations of 2,3-BD and AC in the
supernatant were analyzed by GC. Prior to GC analysis, the
supernatant was extracted with an equal volume of ethyl acetate
after the addition of isoamyl alcohol as the internal standard. The
GC (Agilent GC6820) system consisted of a flame ionization
detector and a fused silica capillary column (Supelco Beta DEX
TM
120, inside diameter, 0.25 mm; length, 30 m). The operating
conditions were as follows. Nitrogen was used as the carrier gas.
The injector temperature and detector temperature were both
280uC. The column oven was maintained at 40uC for 3 min and
then programmed to increase to 80uC at a rate of 1.5uC min
21.
The temperature was then raised to 86uC at a rate of 0.5uC min
21
and finally to 200uC at a rate of 30uC min
21. The injection
volume was 3 mL. In this study, the ee values of (3S)-AC and (3R)-
AC were calculated as
S ½  { R ½ 
S ½  z R ½  |100% and
R ½  { S ½ 
R ½  z S ½  |100%,
respectively, where [R] and [S] represent the concentrations of
(3R)-AC and (3S)-AC, respectively.
Figure 5. GC analyses of substrates and products of the
catalytic reaction (* Isoamyl alcohol was used as the internal
standard). A. Conversion of meso-2,3-BD to (3S)-AC: A1-before the
reaction; A2-after the reaction; B. Conversion of (2R,3R)-2,3-BD to (3R)-
AC: B1-before the reaction; B2-after the reaction; C. The starting
material and products of kinetic resolution from a mixture of 2,3-BD: C1-
before the reaction; C2-after the reaction.
doi:10.1371/journal.pone.0008860.g005
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Scheme S1 The reactions catalyzed by (2R,3R)-2,3-butanediol
dehydrogenase.
Found at: doi:10.1371/journal.pone.0008860.s001 (0.27 MB TIF)
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Table 2. Strains, plasmids, and primers used in this study.
Bacterium, plasmid or primer Genotype, properties or sequence Source or reference
Strain
L. brevis Wild type lactic acid fermentation CICC 6004
B. subtilis 168 Wild type ATCC 23857
E. coli DH5a supE44 D lacU169 (Q80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Novagen
E. coli BL21 (DE3) F
2 ompT hsdSB (rB
2mB
2)g a l( l cI8 5 7i n d 1S a m 7n i n 5l a c U V 5T 7 g e n e 1 )d c m( D E 3 ) Novagen
Plasmid
pEasy-Blunt Cloning vector; Amp
r Transgene
pETDuet-1 Overexpression vector; Amp
r Novagen
pETDuet-ydjL ydjL in pETDuet-1 This study
pETDuet-nox nox in pETDuet-1 This study
pETDuet-ydjLnox ydjL and nox in pETDuet-1 This study
Primer
py1 59-TCACCATGGGCATGAAGGCAGCAAGA-39 This study
py2 59-GGCGTCGACTTAGTTAGGTCTAACA-39 This study
pn1 59-GCGAGATCTCATGAAAGTCACAGTTG-39 This study
pn2 59-GATCTCGAGTTAAGCGTTAACTGAT-39 This study
The italic face indicates the introduction of restriction sites.
doi:10.1371/journal.pone.0008860.t002
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